Vasodilator therapy--a physiologic approach to the treatment of heart failure.

Experiments on isolated cardiac tissue have established that myocardial-fiber shortening is dependent on three factors: the preload, which determines the muscle fiber's end-diastolic length; the co...

[1]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[2]  R R Miller,et al.  Combined Dopamine and Nitroprusside Therapy in Congestive Heart Failure: Greater Augmentation of Cardiac Performance by Addition of Inotropic Stimulation to Afterload Reduction , 1977, Circulation.

[3]  B. Massie,et al.  Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.

[4]  K. Shine,et al.  Vasodilator Therapy for Chronic Left Ventricular Failure , 1976, Circulation.

[5]  W. Grossman,et al.  Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin. , 1975, Annals of internal medicine.

[6]  J. A. Snow,et al.  Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. , 1974, Annals of internal medicine.

[7]  S. Taylor,et al.  Phentolamine for vasodilator treatment of severe heart-failure. , 1971, Lancet.

[8]  J. Ross,et al.  The Study of Left Ventricular Function in Man by Increasing Resistance to Ventricular Ejection with Angiotensin , 1964, Circulation.

[9]  E. Braunwald,et al.  Hemodynamic Effects of Quantitatively Varied Experimental Mitral Regurgitation , 1957, Circulation research.

[10]  R. Clauss,et al.  Assisted circulation. I. The arterial counterpulsator. , 1961, The Journal of thoracic and cardiovascular surgery.

[11]  E. Braunwald,et al.  The effects of acutely increased systemic resistance on the left atrial pressure pulse: a method for the clinical detection of mitral insufficiency. , 1958, The Journal of clinical investigation.